|
1CHP
SURPRISING LEADS FOR A CHOLERA TOXIN RECEPTOR BINDING ANTAGONIST; CRYSTALLOGRAPHIC STUDIES OF CTB MUTANTS
Deposited 1995-02-15
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Mutation:G33D
Mutation:G33D
Mutation:G33D
Mutation:G33D
Mutation:G33D
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.5
|
Resolution 2.00 Å
|
|
1CHQ
SURPRISING LEADS FOR A CHOLERA TOXIN RECEPTOR BINDING ANTAGONIST; CRYSTALLOGRAPHIC STUDIES OF CTB MUTANTS
Deposited 1995-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
29–131(103 aa)
Chain E
29–131(103 aa)
Chain F
29–131(103 aa)
Chain G
29–131(103 aa)
Chain H
29–131(103 aa)
|
Mutation:R35D
Mutation:R35D
Mutation:R35D
Mutation:R35D
Mutation:R35D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;pH 6.4
|
Resolution 2.10 Å
|
|
1CT1
CHOLERA TOXIN B-PENTAMER MUTANT G33R BOUND TO RECEPTOR PENTASACCHARIDE
Deposited 1997-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Fragment:B-PENTAMER
Chain E
22–124(103 aa)
Fragment:B-PENTAMER
Chain F
22–124(103 aa)
Fragment:B-PENTAMER
Chain G
22–124(103 aa)
Fragment:B-PENTAMER
Chain H
22–124(103 aa)
Fragment:B-PENTAMER
|
Mutation:G33R
Mutation:G33R
Mutation:G33R
Mutation:G33R
Mutation:G33R
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
PROTEIN, 20 MM TRIS, 1 MM GM1-OS, PH 7.5 200 MM MGCL2, 100 MM CACODYLATE, 19% PEG 1000, 0.2% AGAROSE, PH 7.2
|
Resolution 2.30 Å
R-free 0.250
|
|
1FGB
TOXIN
Deposited 1996-02-21
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.40 Å
|
|
1G8Z
HIS57ALA MUTANT OF CHOLERA TOXIN B-PENATMER
Deposited 2000-11-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Mutation:H57A
Mutation:H57A
Mutation:H57A
Mutation:H57A
Mutation:H57A
|
GAL beta-D-galactopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.4;298 K;PEG 5000, NaCl, Tris HCl, galactose, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å
R-free 0.239
|
|
1JR0
CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0011
Deposited 2001-08-09
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
A24 (3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;PEG 3000, NaCl, MgCl2, Tris HCl, pH 7.5, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.30 Å
R-free 0.183
|
|
1JR0
CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0011
Deposited 2001-08-09
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 10
PDB declaration: decameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
A24 (3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;PEG 3000, NaCl, MgCl2, Tris HCl, pH 7.5, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.30 Å
R-free 0.183
|
|
1RCV
Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV1
Deposited 2003-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
BV1 [3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO] -2-(3-{4-[3-(3-NITRO-5-[GALACTOPYRANOSYLOXY]-BENZOYLAMINO)-PROPYL]-PIPERAZIN-1-YL} -PROPYL-AMINO)-3,4-DIOXO-CYCLOBUTENE × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;30% PEG 300, 50 mM NaCl, 100 mM Tris-HCl, and 2.3mM BV1, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.60 Å
R-free 0.193
|
|
1RD9
Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV2
Deposited 2003-11-05
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
BV2 1,3-BIS-([3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYL-AMINO]-CARBONYLOXY)-2-AMINO-PROPANE × 5
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
P6G HEXAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;38% PEG 300, 50 mM NaCl, 100 mM Tris-HCl, and 2.3mM BV2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.44 Å
R-free 0.184
|
|
1RDP
Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV3
Deposited 2003-11-05
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
BV3 1,3-BIS-([[3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO-3,4-DIOXO-CYCLOBU TENYL]-AMINO-ETHYL]-AMINO-CARBONYLOXY)-2-AMINO-PROPANE × 5
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;12% PEG 8000, 50 mM NaCl, 100 mM Tris-HCl, 20mM MgCl2, and 2.3mM BV3, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.35 Å
R-free 0.171
|
|
1RF2
Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV4
Deposited 2003-11-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
BV4 1,3-BIS-([3-[3-[3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO-3,4-DIOXO-CYCLOBUTENYL]-AMINO-PROPOXY-ETHOXY-ETHOXY]-PROPYL-]AMINO-CARBONYLOXY)-2-AMINO-PROPANE × 5
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;16% PEG 8000, 50 mM NaCl, 100 mM Tris-HCl, 20mM MgCl2, and 2.3mM BV4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.35 Å
R-free 0.174
|
|
1S5B
Cholera holotoxin with an A-subunit Y30S mutation Form 3
Deposited 2004-01-20
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;PEG 2000mme, MES, kemptide, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.13 Å
R-free 0.224
|
|
1S5C
Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 1
Deposited 2004-01-20
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;PEG 2000mme, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.262
|
|
1S5D
Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 2
Deposited 2004-01-20
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
GOL GLYCEROL × 5
GAL beta-D-galactopyranose × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, sodium citrate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.75 Å
R-free 0.191
|
|
1S5E
Cholera holotoxin, Crystal form 1
Deposited 2004-01-20
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
GAL beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, magnesium acetate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.90 Å
R-free 0.205
|
|
1S5E
Cholera holotoxin, Crystal form 1
Deposited 2004-01-20
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
Chain M
22–124(103 aa)
Chain N
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
GAL beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, magnesium acetate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.90 Å
R-free 0.205
|
|
1XTC
CHOLERA TOXIN
Deposited 1996-01-10
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.40 Å
|
|
2CHB
CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE
Deposited 1997-06-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Fragment:B-PENTAMER
Chain E
22–124(103 aa)
Fragment:B-PENTAMER
Chain F
22–124(103 aa)
Fragment:B-PENTAMER
Chain G
22–124(103 aa)
Fragment:B-PENTAMER
Chain H
22–124(103 aa)
Fragment:B-PENTAMER
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;200 MM MGCL2 100 MM CACODYLATE 5% PEG 1000 PH 7.5
|
Resolution 2.00 Å
|
|
3CHB
CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE
Deposited 1998-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–124(124 aa)
Fragment:B-PENTAMER
Chain E
1–124(124 aa)
Fragment:B-PENTAMER
Chain F
1–124(124 aa)
Fragment:B-PENTAMER
Chain G
1–124(124 aa)
Fragment:B-PENTAMER
Chain H
1–124(124 aa)
Fragment:B-PENTAMER
|
Mutation:H94R
Mutation:H94R
Mutation:H94R
Mutation:H94R
Mutation:H94R
|
UNX UNKNOWN LIGAND × 5
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;SITTING DROP, pH 7.0, vapor diffusion - sitting drop
|
Resolution 1.25 Å
R-free 0.180
|
|
5ELC
Cholera toxin El Tor B-pentamer in complex with Lewis-y
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded
|
CA CALCIUM ION × 10
BCN BICINE × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 12.5% PEG1000, 12.5% PEG3350, 12.5% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.50 Å
R-free 0.260
|
|
5ELC
Cholera toxin El Tor B-pentamer in complex with Lewis-y
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded
|
FUC alpha-L-fucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 12.5% PEG1000, 12.5% PEG3350, 12.5% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.50 Å
R-free 0.260
|
|
5ELE
Cholera toxin El Tor B-pentamer in complex with A Lewis-y
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded
|
CA CALCIUM ION × 10
FUC alpha-L-fucopyranose × 1
BCN BICINE × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.60 Å
R-free 0.226
|
|
5ELE
Cholera toxin El Tor B-pentamer in complex with A Lewis-y
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded
|
FUC alpha-L-fucopyranose × 3
1PE PENTAETHYLENE GLYCOL × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.60 Å
R-free 0.226
|
|
5ELF
Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded
|
CA CALCIUM ION × 10
BCN BICINE × 10
FUC alpha-L-fucopyranose × 1
GLC alpha-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride. Microseeding.
|
Resolution 1.55 Å
R-free 0.220
|
|
5ELF
Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide
Deposited 2015-11-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded
|
FUC alpha-L-fucopyranose × 1
GLC alpha-D-glucopyranose × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride. Microseeding.
|
Resolution 1.55 Å
R-free 0.220
|
|
5LZG
Cholera toxin El Tor B-pentamer in complex with inhibitor PC262
Deposited 2016-09-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded
|
7BN (2~{R},4~{S},5~{R},6~{R})-5-acetamido-2-[4-[3-[2-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethylamino]-3-oxidanylidene-propyl]-1,2,3-triazol-1-yl]-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid × 5
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
IMD IMIDAZOLE × 2
PEG DI(HYDROXYETHYL)ETHER × 1
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES/Imidazole buffer, pH 6.5, 10% PEG 1000, 10 % PEG 3350, 10 % MPD, 0.03 M divalent cations
|
Resolution 1.13 Å
R-free 0.198
|
|
5LZJ
Cholera toxin El Tor B-pentamer in complex with inhibitor Laura237
Deposited 2016-09-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
PEG DI(HYDROXYETHYL)ETHER × 2
PGE TRIETHYLENE GLYCOL × 2
7BT (~{Z})-~{N}-[2-[(2~{R},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M MES pH 6, 30% PEG 400, 3% PGA-LM
|
Resolution 1.20 Å
R-free 0.228
|
|
8OXS
Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 4 C-terminal substitutions)
Deposited 2023-05-02
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
GAL beta-D-galactopyranose × 6
GLA alpha-D-galactopyranose × 4
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;Crystallization mix:
20% w/v PEG 6K
0.1 M HEPES pH 7.0
0.2 M NH4Cl
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
0.05 M D-(+)-galactose
|
Resolution 1.60 Å
R-free 0.224
|
|
8OXS
Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 4 C-terminal substitutions)
Deposited 2023-05-02
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 1
GAL beta-D-galactopyranose × 4
GLA alpha-D-galactopyranose × 3
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;Crystallization mix:
20% w/v PEG 6K
0.1 M HEPES pH 7.0
0.2 M NH4Cl
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
0.05 M D-(+)-galactose
|
Resolution 1.60 Å
R-free 0.224
|
|
8Q6I
Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 1 C-terminal substitution)
Deposited 2023-08-11
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 2
GOL GLYCEROL × 11
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;Crystallization mix:
20% PEG6000
0.2 M lithium chloride
0.1 M Tris pH 8.0
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
|
Resolution 1.60 Å
R-free 0.222
|
|
8QRE
Cholera holotoxin (wildtype)
Deposited 2023-10-06
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 2
GAL beta-D-galactopyranose × 6
GOL GLYCEROL × 7
ACT ACETATE ION × 2
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293.15 K;Crystallization mix:
0.125 M Magnesium acetate
24% PEG 3350
300 mM galactose (in protein storage buffer)
Protein storage buffer:
50 mM Tris pH 7.4
200 mM NaCl
1 mM EDTA
3 mM sodium azide
|
Resolution 2.30 Å
R-free 0.263
|
|
8QRE
Cholera holotoxin (wildtype)
Deposited 2023-10-06
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
|
Not recorded
|
NA SODIUM ION × 2
GAL beta-D-galactopyranose × 4
GOL GLYCEROL × 7
ACT ACETATE ION × 1
GLA alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293.15 K;Crystallization mix:
0.125 M Magnesium acetate
24% PEG 3350
300 mM galactose (in protein storage buffer)
Protein storage buffer:
50 mM Tris pH 7.4
200 mM NaCl
1 mM EDTA
3 mM sodium azide
|
Resolution 2.30 Å
R-free 0.263
|
|
9EWF
Cholera toxin B subunit in complex with fluorinated GM1
Deposited 2024-04-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded
|
A1H7V (2R,3S,4S,5R,6R)-6-dodecoxy-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MES/Imidazole pH 7.5, 0.03M MgCl2, 0.03M CaCl2, 16% PEG1000, 12% PEG3350 and 10% MPD
|
Resolution 2.10 Å
R-free 0.221
|
|
9EWF
Cholera toxin B subunit in complex with fluorinated GM1
Deposited 2024-04-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded
|
A1H7V (2R,3S,4S,5R,6R)-6-dodecoxy-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MES/Imidazole pH 7.5, 0.03M MgCl2, 0.03M CaCl2, 16% PEG1000, 12% PEG3350 and 10% MPD
|
Resolution 2.10 Å
R-free 0.221
|